Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

IGC Pharma, Inc.

NYSE: IGC · Life Sciences · 1 alert · CIK 1326205

Share price
$0.1750Close, Nov 16
Market cap
$20.4M
Shares outstanding
116.69MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All IGC Pharma, Inc. filings on SEC EDGAR ↗

4:02 PM ET 10-Q
Financial Results

IGC Pharma Q3 2026 Results: Net Loss of $2.05M, Loss Widens

IGC Pharma, Inc. reported a net loss of $7.38 million for the nine months ended September 30, 2026, compared to a $4.62 million loss in the prior year period. While revenue increased slightly to $910,000, the company's operating loss widened due to higher research and development and administrative expenses related to its clinical trials.

Key figure
Net loss $2.05M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.